Hyaluronic acid solution injection for upper and lower gastrointestinal bleeding after failed conventional endoscopic therapy

2013 ◽  
Vol 26 (2) ◽  
pp. 285-290 ◽  
Author(s):  
Jin Wook Lee ◽  
Hyung Hun Kim
Keyword(s):  
Hyaluronic Acid ◽  
Gastrointestinal Bleeding ◽  
Acid Solution ◽  
Endoscopic Therapy ◽  
Lower Gastrointestinal Bleeding

Colonoscopy Delay in Lower Gastrointestinal Bleeding: Influence On Diagnostic Accuracy, Endoscopic Therapy and Hospital Stay

2007 ◽  
Vol 65 (5) ◽  
pp. AB261 ◽  
Author(s):  
Francisco Rodriguez-Moranta ◽  
Ana Berrozpe ◽  
Josep M. Botargues ◽  
Antonio Soriano-Izquierdo ◽  
Nadia Chahri ◽  
...  
Keyword(s):  
Gastrointestinal Bleeding ◽  
Diagnostic Accuracy ◽  
Hospital Stay ◽  
Endoscopic Therapy ◽  
Lower Gastrointestinal Bleeding

scholarly journals A180 SENSITIVITY AND SPECIFICITY OF LOWER GASTROINTESTINAL BLEEDING SCORES TO PREDICT ADVERSE OUTCOMES: SYSTEMATIC REVIEW AND META-ANALYSIS

2020 ◽  
Vol 3 (Supplement_1) ◽  
pp. 47-48
Author(s):  
M M Almaghrabi ◽  
M Gandhi ◽  
A Iansavitchene ◽  
V Jairath ◽  
M Sey
Keyword(s):  
Systematic Review ◽  
Blood Transfusion ◽  
Gastrointestinal Bleeding ◽  
Risk Prediction ◽  
Full Text ◽  
Endoscopic Therapy ◽  
Meta Analysis ◽  
Lower Gastrointestinal Bleeding ◽  
Risk Scores ◽  
Full Text Review

Abstract Background Acute lower gastrointestinal bleeding (LGIB) is a common reason for emergency hospitalization. In most patients bleeding resolves spontaneously, although some presentations result in adverse outcome such as transfusion, therapeutic intervention, rebleeding and mortality. Risk prediction scores are important to stratify patients at presentation with LGIB. Aims To perform a systematic review and meta-analysis comparing LGIB risk prediction scores. We provide a summary effect measure of their predictive values for 30-day mortality, safe discharge, rebleeding, need for blood transfusion, and need for endoscopic therapy/IR/surgery. Methods Electronic search for relevant publications after 1990 was conducted in PubMed, EMBASE, Web of Science, Cochrane Central Register of Controlled Trials, NIH ClinicalTrials.gov, and Cochrane Database of Systematic Reviews. We also searched relevant published conference abstracts over the past 5 years. Studies with a primary goal of deriving or validating a LGIB risk score were included. Title and abstracts were reviewed by two independent reviewers and then full text review was done by both reviewers. Results Our search identified 1,832 citations for review. After title and abstract review, 68 publications were selected for full text review. So far, a total of 16 citations were excluded since we started full text review including: insufficient information (n=14), review article (n=2). Thus far, we identified 14 risk scores and algorithms from 9 studies. Two of the risk scores are UGIB risk scores that were assessed for LGIB. Of these studies, 3 were validation studies, one derivation study and five for both validation and derivation. The scores assessed safety of discharge (n=3), mortality (n=4), need for therapy (n=8), severe bleeding (n=8) and requirement for blood transfusion (n=1). A meta-analysis will follow. Conclusions We conducted a systematic review of LGIB risk scores, with a meta-analysis to follow if appropriate, for use to predict 30-day mortality, safe discharge, rebleeding, required blood transfusion, endoscopic therapy/IR/surgery. Funding Agencies None

scholarly journals Dieulafoy's Lesions of the Rectum: A Rare Cause of Lower Gastrointestinal Bleeding

2001 ◽  
Vol 15 (8) ◽  
pp. 541-545 ◽  
Author(s):  
Robert Enns
Keyword(s):  
Differential Diagnosis ◽  
Gastrointestinal Bleeding ◽  
Endoscopic Therapy ◽  
Present Report ◽  
Lower Gastrointestinal Bleeding ◽  
Injection Sclerotherapy ◽  
Surgical Anastomosis ◽  
Dieulafoy’S Lesion ◽  
Adrenaline Injection

Dieulafoy's lesions located outside of the stomach are rare occurrences. Lesions found within the colon typically present with painless, massive hematochezia (ie, greater than 5 U). If they can be accurately located, endoscopic therapy in the form of adrenaline injection, sclerotherapy or cauterization appears to have long term success. The present report details the case of a 72-year-old man who presented with massive hematochezia and who was discovered to have a Dieulafoy's lesion within the rectum. The lesion was located just distal to a previous surgical anastomosis, and was successfully treated with adrenaline and electrocautery. Colonic Dieulafoy's lesions are rare but should always be considered in the differential diagnosis of massive hematochezia, because endoscopic therapy appears to result in complete cessation of bleeding.

Sign in / Sign up

Export Citation Format

Share Document